EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance

Amirali Hariri, Mina Mirian, Arezoo Khosravi, Atefeh Zarepour, Siavash Iravani, Ali Zarrabi

Drug Resistance Updates · 2024-09 · 76 · 101119

DOI: 10.1016/j.drup.2024.101119 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2024-09. Verfasst von Amirali Hariri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 817467346…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Epithelial-Mesenchymal Transition, Drug Resistance, Neoplasm, Tumor Microenvironment. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 198 Literaturangaben. Gefördert von: Isfahan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer metastasis and therapy resistance are intricately linked with the dynamics of Epithelial-Mesenchymal Transition (EMT) and Circulating Tumor Cells (CTCs). EMT hybrid cells, characterized by a blend of epithelial and mesenchymal traits, have emerged as pivotal in metastasis and demonstrate remarkable plasticity, enabling transitions across cellular states crucial for intravasation, survival in circulation, and extravasation at distal sites. Concurrently, CTCs, which are detached from primary tumors and travel through the bloodstream, are crucial as potential biomarkers for cancer prognosis and therapeutic response. There is a significant interplay between EMT hybrid cells and CTCs, revealing a complex, bidirectional relationship that significantly influences metastatic progression and has a critical role in cancer drug resistance. This resistance is further influenced by the tumor microenvironment, with factors such as tumor-associated macrophages, cancer-associated fibroblasts, and hypoxic conditions driving EMT and contributing to therapeutic resistance. It is important to understand the molecular mechanisms of EMT, characteristics of EMT hybrid cells and CTCs, and their roles in both metastasis and drug resistance. This comprehensive understanding sheds light on the complexities of cancer metastasis and opens avenues for novel diagnostic approaches and targeted therapies and has significant advancements in combating cancer metastasis and overcoming drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingEpithelial-Mesenchymal TransitionDrug Resistance, NeoplasmTumor MicroenvironmentNeoplasm MetastasisNeoplasmsHumansAntineoplastic AgentsAnimalsBiomarkers, TumorM Cells

Stichwörter der Autor:innen

Cancer metastasisCircular tumor cellsDrug resistanceEpithelial-mesenchymal transition

Substanzen

Antineoplastic AgentsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran.
  • Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran. Electronic address: mina.mirian@pharm.mui.ac.ir.
  • Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, Istanbul Okan University, Istanbul 34959, Turkiye.
  • Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600 077, India.
  • Independent Researcher, W Nazar ST, Boostan Ave, Isfahan, Iran. Electronic address: siavashira@gmail.com.
  • Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul 34396, Turkiye; Graduate School of Biotechnology and Bioengineering, Yuan Ze University, Taoyuan 320315, Ta…

Förderung

  • Isfahan University of Medical Sciences

Zitieren

APA

Hariri, A., Mirian, M., Khosravi, A., Zarepour, A., Iravani, S., & Zarrabi, A. (2024). Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance. Drug Resistance Updates, 76, 101119. https://doi.org/10.1016/j.drup.2024.101119

Vancouver

Hariri A, Mirian M, Khosravi A, Zarepour A, Iravani S, Zarrabi A. Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance. Drug Resistance Updates. 2024;76:101119. doi:10.1016/j.drup.2024.101119

BibTeX
@article{Hariri2024,
  author = {Hariri, Amirali and Mirian, Mina and Khosravi, Arezoo and Zarepour, Atefeh and Iravani, Siavash and Zarrabi, Ali},
  title = {Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {76},
  pages = {101119},
  doi = {10.1016/j.drup.2024.101119}
}
Kostenlos starten →